Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs SUPRIYA LIFESCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA SUPRIYA LIFESCIENCE SUN PHARMA/
SUPRIYA LIFESCIENCE
 
P/E (TTM) x 42.0 23.0 183.0% View Chart
P/BV x 6.8 4.0 170.8% View Chart
Dividend Yield % 0.7 0.2 417.8%  

Financials

 SUN PHARMA   SUPRIYA LIFESCIENCE
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
SUPRIYA LIFESCIENCE
Mar-23
SUN PHARMA/
SUPRIYA LIFESCIENCE
5-Yr Chart
Click to enlarge
High Rs1,072515 208.0%   
Low Rs790170 464.4%   
Sales per share (Unadj.) Rs182.950.4 363.1%  
Earnings per share (Unadj.) Rs35.711.2 319.6%  
Cash flow per share (Unadj.) Rs46.212.6 365.9%  
Dividends per share (Unadj.) Rs11.500.60 1,916.7%  
Avg Dividend yield %1.20.2 705.7%  
Book value per share (Unadj.) Rs233.486.9 268.5%  
Shares outstanding (eoy) m2,399.3480.48 2,981.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.16.8 74.8%   
Avg P/E ratio x26.130.7 85.0%  
P/CF ratio (eoy) x20.127.1 74.2%  
Price / Book Value ratio x4.03.9 101.1%  
Dividend payout %32.25.4 599.7%   
Avg Mkt Cap Rs m2,233,36127,581 8,097.3%   
No. of employees `000NANA-   
Total wages/salary Rs m82,960556 14,926.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m438,8574,054 10,825.1%  
Other income Rs m8,199100 8,205.9%   
Total revenues Rs m447,0554,154 10,762.1%   
Gross profit Rs m112,9001,284 8,789.9%  
Depreciation Rs m25,294118 21,408.6%   
Interest Rs m1,72031 5,491.7%   
Profit before tax Rs m94,0841,235 7,619.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,476336 2,520.3%   
Profit after tax Rs m85,608899 9,527.2%  
Gross profit margin %25.731.7 81.2%  
Effective tax rate %9.027.2 33.1%   
Net profit margin %19.522.2 88.0%  
BALANCE SHEET DATA
Current assets Rs m398,6194,649 8,574.5%   
Current liabilities Rs m199,064958 20,783.2%   
Net working cap to sales %45.591.0 49.9%  
Current ratio x2.04.9 41.3%  
Inventory Days Days14724 622.6%  
Debtors Days Days9576 124.8%  
Net fixed assets Rs m376,9603,554 10,606.9%   
Share capital Rs m2,399161 1,490.5%   
"Free" reserves Rs m557,5556,834 8,159.0%   
Net worth Rs m559,9546,995 8,005.5%   
Long term debt Rs m00-   
Total assets Rs m775,7948,203 9,457.7%  
Interest coverage x55.740.4 137.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 114.5%   
Return on assets %11.311.3 99.3%  
Return on equity %15.312.8 119.0%  
Return on capital %17.118.1 94.5%  
Exports to sales %088.8 0.0%   
Imports to sales %023.5 0.0%   
Exports (fob) Rs mNA3,598 0.0%   
Imports (cif) Rs mNA953 0.0%   
Fx inflow Rs m154,0533,598 4,281.5%   
Fx outflow Rs m71,511953 7,502.3%   
Net fx Rs m82,5412,645 3,120.7%   
CASH FLOW
From Operations Rs m49,593662 7,492.9%  
From Investments Rs m-79,437-1,331 5,966.2%  
From Financial Activity Rs m23,761-34 -70,569.3%  
Net Cashflow Rs m1,155-703 -164.2%  

Share Holding

Indian Promoters % 54.5 68.3 79.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 10.0 367.7%  
FIIs % 17.1 4.6 374.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 31.7 143.6%  
Shareholders   612,626 95,929 638.6%  
Pledged promoter(s) holding % 2.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   CIPLA    LUPIN    DR. REDDYS LAB    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Sun Pharma vs SUPRIYA LIFESCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs SUPRIYA LIFESCIENCE Share Price Performance

Period Sun Pharma SUPRIYA LIFESCIENCE S&P BSE HEALTHCARE
1-Day 0.19% 0.59% -0.68%
1-Month 12.65% 13.18% 5.94%
1-Year 64.70% 73.40% 62.40%
3-Year CAGR 37.65% -4.16% 18.40%
5-Year CAGR 28.76% -2.52% 20.58%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the SUPRIYA LIFESCIENCE share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of SUPRIYA LIFESCIENCE the stake stands at 68.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of SUPRIYA LIFESCIENCE .

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 11.5 per share. This amounted to a Dividend Payout ratio of 32.2%.

SUPRIYA LIFESCIENCE paid Rs 0.6, and its dividend payout ratio stood at 5.4%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of SUPRIYA LIFESCIENCE .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 195 Points Higher | PSB Index Up 2% | Berger Paints Rallies 10% Sensex Today Ends 195 Points Higher | PSB Index Up 2% | Berger Paints Rallies 10%(Closing)

After opening the flat, Indian share markets turned positive as the session progressed and ended the day higher.